By CapitalSnitch Research Desk · updated Oct 11, 2026 · data from SEC filings and official Congress disclosures
No open-market selling at Standard Biotools Inc. in the past year, which is unusual. Instead five corporate insiders bought about $14.4 million worth of LAB.
Biggest single buyer: Casdin Partners GP, LLC, Director, with roughly $9.8 million.
On the institutional side, 143 funds reported holding LAB at the end of Q2 2026, and funds were split between buying and selling. Quarter by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 3 of the last 7 full quarters.
Are insiders buying or selling LAB stock?
In the last 12 months Standard Biotools Inc. insiders made open-market purchases worth about $14.4 million and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
When was the last insider trade in LAB?
The most recent open-market insider trade in LAB was filed on 2025-12-04.
How many institutions own LAB?
143 investment managers reported holding LAB in SEC Form 13F filings for Q2 2026.
Has any member of Congress traded LAB?
No congressional trades in LAB were reported in the past two years. The full list is free on CapitalSnitch.
Free weekly email: the week's biggest insider buys and Congress trades, every Monday. No spam, one-click unsubscribe.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1).
Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).